Published in Acta Otorhinolaryngol Ital on February 01, 2010
Supra-thyroid alar cartilage approach for the complete resection of laryngeal submucosal tumors and postoperative voice quality. Eur Arch Otorhinolaryngol (2015) 0.97
Lipoma of paraglottic space in a child: a case report. Iran J Otorhinolaryngol (2014) 0.75
Lipoma excision. Am Fam Physician (2002) 2.25
Lipomas of the head and neck: presentation variability and diagnostic work-up. J Laryngol Otol (2005) 1.89
Rare benign tumors: laryngeal and hypopharyngeal lipomata. Ann Otol Rhinol Laryngol (2000) 1.65
Rare presentations of ordinary lipomas of the head and neck: a review. AJNR Am J Neuroradiol (1986) 1.51
Rare benign neoplasms of the larynx: rhabdomyoma and lipoma. ORL J Otorhinolaryngol Relat Spec (1996) 1.47
Spindle cell lipoma of the hypopharynx. Dysphagia (2001) 1.34
Multiple symmetric lipomatosis: an updated clinical report. Medicine (Baltimore) (1984) 1.29
A rare case of a pedunculated lipoma in the pharynx. Emerg Med J (2002) 1.27
Lipomas of the larynx and hypopharynx: a review of the literature with the addition of three new cases. J Laryngol Otol (1995) 1.20
Laryngeal involvement in benign symmetric lipomatosis. Arch Otolaryngol (1973) 1.17
Acute stridor caused by a previously asymptomatic large oropharyngeal spindle cell lipoma. Auris Nasus Larynx (2007) 1.12
Laryngeal and hypopharyngeal liposarcoma. A clinicopathologic study of 10 cases with a comparison to soft-tissue counterparts. Am J Surg Pathol (1990) 1.05
Liposarcomas of the larynx and hypopharynx: a clinicopathologic study of eight new cases and a review of the literature. Laryngoscope (1995) 0.99
Benign symmetrical lipomatosis (Madelung's disease). Case report. Plast Reconstr Surg (1976) 0.97
Myxolipoma of the epiglottis in an adult: a case report. Ear Nose Throat J (2005) 0.93
Liposarcoma of the larynx. Case report and literature review. Arch Otolaryngol Head Neck Surg (1986) 0.91
Lipoma of the hypopharynx producing menacing symptoms. AMA Arch Otolaryngol (1952) 0.89
Parapharyngeal lipoma extending to skull base: a case report and review of the literature. Skull Base (2004) 0.88
Lipoma of the hypopharynx: pre-operative diagnosis and transoral resection. J Laryngol Otol (1994) 0.87
Laryngeal liposarcoma. Arch Otolaryngol Head Neck Surg (1994) 0.87
Giant lipoma of the larynx: a case report and literature review. Ear Nose Throat J (1999) 0.87
Spindle cell lipoma within the larynx: a case report with correlated light and electron microscopy. ORL J Otorhinolaryngol Relat Spec (1993) 0.87
Lipoma of the larynx. Report of 2 cases and review of the literature. Otolaryngol Pol (2002) 0.86
Surgical approach to a giant fibrolipoma of the supraglottic larynx. J Laryngol Otol (2000) 0.85
Primary liposarcoma of the larynx. Case report and literature review. Ann Otol Rhinol Laryngol (1994) 0.85
Benign pedunculated tumours of the hypopharynx. 3 case reports, 1 with late malignant transformation. ORL J Otorhinolaryngol Relat Spec (1985) 0.83
Improved detection and delineation of head and neck lesions with fat suppression spin-echo MR imaging. AJNR Am J Neuroradiol (1991) 0.82
[Improved diagnosis of laryngeal lipoma by computerized tomography]. HNO (1988) 0.82
Fibrolipoma of the pyriform sinuses: thirty-seven year follow-up. Laryngoscope (1982) 0.81
Pedunculated lipoma of the epiglottis. Second known case reported. Arch Otolaryngol (1973) 0.81
Lipoma of the larynx. Am J Otolaryngol (1994) 0.81
[Lipoma of the hypopharynx: role of computerized tomography in the diagnosis protocol]. Acta Otorhinolaryngol Ital (1990) 0.81
[Laryngeal fibrolipoma: a case report]. Acta Otorrinolaringol Esp (1996) 0.77
Myxoid laryngeal lipoma in a juvenile. Otolaryngol Head Neck Surg (1990) 0.77
Laryngeal lipoma. Ear Nose Throat J (1991) 0.77
Lipoma of the larynx. Ear Nose Throat J (1976) 0.77
[Retro-pharyngeal and pharyngeal-laryngeal lipomas]. Ann Otolaryngol Chir Cervicofac (2000) 0.76
[Fibrolipoma of the larynx]. Laryngorhinootologie (2002) 0.76
Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2. Proc Natl Acad Sci U S A (1998) 5.74
Gain of function mutations in p53. Nat Genet (1993) 4.19
An oncogene isolated by transfection of Kaposi's sarcoma DNA encodes a growth factor that is a member of the FGF family. Cell (1987) 3.78
Replacement of Fhit in cancer cells suppresses tumorigenicity. Proc Natl Acad Sci U S A (1997) 2.36
Analysis of RAS oncogene mutations in human lymphoid malignancies. Proc Natl Acad Sci U S A (1988) 2.01
Structure of the rat osteocalcin gene and regulation of vitamin D-dependent expression. Proc Natl Acad Sci U S A (1989) 1.98
Biochemical and pharmacological characterization of the cyclooxygenase activity of human blood prostaglandin endoperoxide synthases. J Pharmacol Exp Ther (1994) 1.79
Cytoplasmic sequestration of wild-type p53 protein impairs the G1 checkpoint after DNA damage. Mol Cell Biol (1996) 1.61
Helical CT angiography in gastrointestinal bleeding of obscure origin. AJR Am J Roentgenol (1997) 1.58
Risk of second cancers in Waldenström macroglobulinemia. Ann Oncol (2011) 1.47
Oncogenic rearrangements of the RET proto-oncogene in papillary thyroid carcinomas from children exposed to the Chernobyl nuclear accident. Cancer Res (1995) 1.33
Loss of function effect of RET mutations causing Hirschsprung disease. Nat Genet (1995) 1.33
Molecular cloning of a gene that is necessary for G1 progression in mammalian cells. Proc Natl Acad Sci U S A (1987) 1.29
Deregulated FGFR3 mutants in multiple myeloma cell lines with t(4;14): comparative analysis of Y373C, K650E and the novel G384D mutations. Oncogene (2001) 1.25
Risk of childhood cancer and adult lung cancer after childhood exposure to passive smoke: A meta-analysis. Environ Health Perspect (2000) 1.24
Focal liver lesions: evaluation of the efficacy of gadobenate dimeglumine in MR imaging--a multicenter phase III clinical study. Radiology (2000) 1.21
E2F-1:DP-1 induces p53 and overrides survival factors to trigger apoptosis. Mol Cell Biol (1995) 1.20
Detection of haemoparasites in cattle by reverse line blot hybridisation with a note on the distribution of ticks in Sicily. Vet Parasitol (2001) 1.18
Alternative splicing of the ErbB-4 cytoplasmic domain and its regulation by hedgehog signaling identify distinct medulloblastoma subsets. Oncogene (2006) 1.18
Functional analyses and molecular modeling of two c-Kit mutations responsible for imatinib secondary resistance in GIST patients. Oncogene (2006) 1.17
Targeting of a chimeric human histone fusion mRNA to membrane-bound polysomes in HeLa cells. Proc Natl Acad Sci U S A (1987) 1.16
The oncogenic versions of the Ret and Trk tyrosine kinases bind Shc and Grb2 adaptor proteins. Oncogene (1994) 1.14
Cytogenetics and molecular genetics of carcinomas arising from thyroid epithelial follicular cells. Genes Chromosomes Cancer (1996) 1.13
Numb activates the E3 ligase Itch to control Gli1 function through a novel degradation signal. Oncogene (2010) 1.12
Translation initiation of the insulin-like growth factor I receptor mRNA is mediated by an internal ribosome entry site. J Biol Chem (2000) 1.11
E2F-1 cooperates with topoisomerase II inhibition and DNA damage to selectively augment p53-independent apoptosis. Mol Cell Biol (1997) 1.09
PDGFRalpha, PDGFRbeta and KIT expression/activation in conventional chondrosarcoma. J Pathol (2006) 1.08
RET activation by germline MEN2A and MEN2B mutations. Oncogene (1995) 1.07
FK506 binding protein 51 positively regulates melanoma stemness and metastatic potential. Cell Death Dis (2013) 1.06
IGFBP7: an oncosuppressor gene in thyroid carcinogenesis. Oncogene (2010) 1.05
Isolation of the human gene that complements a temperature-sensitive cell cycle mutation in BHK cells. Mol Cell Biol (1987) 1.04
Detection of novel mRNA splice variants of human ING4 tumor suppressor gene. Oncogene (2007) 1.00
Subcellular localization of histone messenger RNAs on cytoskeleton-associated free polysomes in HeLa S3 cells. J Cell Physiol (1985) 1.00
PCAF ubiquitin ligase activity inhibits Hedgehog/Gli1 signaling in p53-dependent response to genotoxic stress. Cell Death Differ (2013) 1.00
Two different ionotropic receptors are activated by ATP in rat microglia. J Physiol (1999) 0.97
Translational control of viral and host protein synthesis during the course of herpes simplex virus type 1 infection: evidence that initiation of translation is the limiting step. J Gen Virol (1998) 0.96
Rearrangements of TRK proto-oncogene in papillary thyroid carcinomas. J Endocrinol Invest (1995) 0.96
The gene complementing a temperature-sensitive cell cycle mutant of BHK cells is the human homologue of the yeast RPC53 gene, which encodes a subunit of RNA polymerase C (III). Cell Growth Differ (1993) 0.96
Photodynamic therapy for basal cell carcinoma: clinical and pathological determinants of response. J Eur Acad Dermatol Venereol (2010) 0.96
Differential suppression of thromboxane biosynthesis by indobufen and aspirin in patients with unstable angina. Circulation (1997) 0.96
The 3' untranslated region of the B19 parvovirus capsid protein mRNAs inhibits its own mRNA translation in nonpermissive cells. J Virol (1997) 0.94
Increased brain synthesis of prostaglandin E2 and F2-isoprostane in human and experimental transmissible spongiform encephalopathies. J Neuropathol Exp Neurol (2000) 0.94
Down-regulation of microglial cyclo-oxygenase-2 and inducible nitric oxide synthase expression by lipocortin 1. Br J Pharmacol (1999) 0.94
Extended parotidectomy. Acta Otorhinolaryngol Ital (2005) 0.93
Full activation of MEN2B mutant RET by an additional MEN2A mutation or by ligand GDNF stimulation. Oncogene (1998) 0.92
Recurrent inflammatory myofibroblastic tumor of the glottis mimicking malignancy. Am J Otolaryngol (1997) 0.92
In vivo activation of N-methyl-D-aspartate receptors in the rat hippocampus increases prostaglandin E(2) extracellular levels and triggers lipid peroxidation through cyclooxygenase-mediated mechanisms. J Neurochem (2002) 0.91
TIMP3 regulates migration, invasion and in vivo tumorigenicity of thyroid tumor cells. Oncogene (2011) 0.91
Increased CSF levels of prostaglandin E(2) in variant Creutzfeldt-Jakob disease. Neurology (2002) 0.91
Simvastatin protection against acute immune-mediated glomerulonephritis in mice. Kidney Int (2006) 0.90
BK virus infection in AIDS. Am J Surg Pathol (2000) 0.90
The TRK-T1 fusion protein induces neoplastic transformation of thyroid epithelium. Oncogene (2000) 0.89
Malignant cardiac myxoma with cerebral metastases. Surg Neurol (1979) 0.89
Increased levels of the Akt-specific phosphatase PH domain leucine-rich repeat protein phosphatase (PHLPP)-1 in obese participants are associated with insulin resistance. Diabetologia (2011) 0.88
Evaluation of the accuracy of gadobenate dimeglumine-enhanced MR imaging in the detection and characterization of focal liver lesions. AJR Am J Roentgenol (2000) 0.88
Induction of prostaglandin endoperoxide synthase-2 in human monocytes associated with cyclo-oxygenase-dependent F2-isoprostane formation. Br J Pharmacol (1996) 0.88
Universal newborn hearing screening programs in Italy: survey of year 2006. Acta Otolaryngol (2008) 0.87
Influence of cognitive impairment and comorbidity on disability in hospitalized elderly patients. J Nutr Health Aging (2005) 0.86
A novel NTRK1 mutation associated with congenital insensitivity to pain with anhidrosis. Am J Hum Genet (1999) 0.86
Potentiometric determination of carbonic anhydrase activity in rabbit carotid bodies: comparison among normoxic, hyperoxic and hypoxic animals. Neurosci Lett (1994) 0.86
Frailty syndrome is associated with altered circulating redox balance and increased markers of oxidative stress. Int J Immunopathol Pharmacol (2009) 0.86
IRS-1 and IRS-2 are recruited by TrkA receptor and oncogenic TRK-T1. J Cell Physiol (2001) 0.85
Interacting with γ-secretase for treating Alzheimer's disease: from inhibition to modulation. Curr Med Chem (2011) 0.85
Deletion of the lifespan determinant p66(Shc) improves performance in a spatial memory task, decreases levels of oxidative stress markers in the hippocampus and increases levels of the neurotrophin BDNF in adult mice. Exp Gerontol (2007) 0.85
Biliary lipid secretion: immunolocalization and identification of a protein associated with lamellar cholesterol carriers in supersaturated rat and human bile. J Lipid Res (1993) 0.84
Laryngotracheal stenosis treated with multiple surgeries: experience, results and prognostic factors in 70 patients. Acta Otorhinolaryngol Ital (2012) 0.84
Magnetic resonance imaging in neurosarcoidosis. Magn Reson Imaging (1987) 0.84
Dysphagia in amyotrophic lateral sclerosis: prevalence and clinical findings. Acta Neurol Scand (2013) 0.84
Time-related dynamics of variation in core clock gene expression levels in tissues relevant to the immune system. Int J Immunopathol Pharmacol (2012) 0.84
How does illness severity influence depression, health satisfaction and life satisfaction in patients with cardiovascular disease? The mediating role of illness perception and self-efficacy beliefs. Psychol Health (2013) 0.83
Tuberous sclerosis: immunohistochemistry expression of tuberin and hamartin in a 31-week gestational fetus. Fetal Pediatr Pathol (2005) 0.83
Analysis of cytomegalovirus (CMV) viremia using the pp65 antigenemia assay, the amplicor CMV test, and a semi-quantitative polymerase chain reaction test after allogeneic marrow transplantation. Transpl Infect Dis (2007) 0.83
Calcified gastric cancer: report of a case and review of literature. Br J Radiol (1986) 0.83
Treatment of cancer anorexia with megestrol acetate: impact on quality of life. Oncology (Williston Park) (1990) 0.83
Computed tomography visceral adipose tissue volume measurements of Italians. Predictive equations. Eur J Clin Nutr (1996) 0.82
Chemotherapy for advanced thymoma. Preliminary results of an intergroup study. Ann Intern Med (1990) 0.82
Cyclosporin neurotoxicity in cardiac transplant recipients. J Neurol Neurosurg Psychiatry (1988) 0.82
Mutation analysis reveals novel sequence variants in NTRK1 in sporadic human medullary thyroid carcinoma. J Clin Endocrinol Metab (1999) 0.82
Quality control of automatically defined cancer cases by the automated registration system of the Venetian Tumour Registry. Quality control of cancer cases automatically registered. Eur J Public Health (2005) 0.82
Pregnancy detection in mice using ultrasound. Vet Rec (2007) 0.82
Computed-tomographic-guided biopsy of thoracic nodules: a revision of 583 lesions. Clin Ter (2008) 0.82
Prolonged remission of neuro-Behcet disease following autologous transplantation. Int J Immunopathol Pharmacol (2007) 0.81
Position and orientation-selective silencer in protein-coding sequences of the rat osteocalcin gene. Biochemistry (1993) 0.81
Redifferentiating agents in non-radioiodine avid cancer. Q J Nucl Med Mol Imaging (2009) 0.81
[Case report: Acro-necrosis of the upper limbs caused by gemcitabine therapy]. Clin Ter (2003) 0.81
Development of an interfacility transport program for critically ill cardiovascular patients. AACN Clin Issues Crit Care Nurs (1990) 0.81
Circadian rhythmicity of lymphocyte subpopulations and relationship with neuro-endocrine system. J Biol Regul Homeost Agents (2010) 0.81
Autologous serum skin test reactivity and basophil histamine release test in patients with nasal polyposis: preliminary results. Int J Immunopathol Pharmacol (2010) 0.80
Actinomycosis of submandibular gland: an unusual presentation. Acta Otorhinolaryngol Ital (2004) 0.80
Biological activity of the thyroid TRK-T3 oncogene requires signalling through Shc. Br J Cancer (2002) 0.80
Ear involvement in acute promyelocytic leukemia at relapse: a disease-associated 'sanctuary'? Leukemia (2002) 0.80
Possible role of microglial prostanoids and free radicals in neuroprotection and neurodegeneration. Adv Exp Med Biol (1999) 0.80
A psychometric evaluation of the Group Environment Questionnaire in a sample of professional basketball and soccer players. Percept Mot Skills (2013) 0.80
A phase I study of etoposide phosphate administered as a daily 30-minute infusion for 5 days. Clin Pharmacol Ther (1995) 0.80
Immunohistochemical localization of secretogranin II in the rat cerebellum. Neuroscience (1989) 0.79
Effects of nabumetone on prostanoid biosynthesis in humans. Clin Pharmacol Ther (1995) 0.79